Text and Data Mining valid from 2018-05-29
Received: 13 October 2017
Accepted: 9 May 2018
First Online: 29 May 2018
Ethics approval and consent to participate
: Not applicable.
: Sciotec Diagnostic Technologies GmbH holds a patent for the use of IgY and fragments thereof in CD therapy. FF and ES were employed by Sciotec Diagnostic Technologies GmbH, when this study was conducted.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.